Alzheimer’s disease (Late onset)

AD_LO

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.1, F00.10, F00.10G30.1, G30.1, G30.1+F00.10 Cause of death:* ICD-10 — F00.1, F00.10, F00.10*G30.1, G30.1, G30.1+F00.10 2 out of 7 registries used, show all original rules.	11696
4. Check minimum number of events None	11696
5. Include endpoints None	11696
6. Filter based on genotype QC (FinnGen only)	11359

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_LO
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F001\|G301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F001\|G301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Late onset) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Late onset), excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11359	5598	5761
Unadjusted period prevalence (%)	2.32	1.99	2.64
Median age at first event (years)	80.92	80.95	80.90

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11103: Matched controls
93376

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

104.3

323.3

195

F009, G309,

ICD-10 Finland

1422.0

307.8

319

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.7

307.7

3491

5980

P70

ICPC

Dementia

16.0

307.7

1585

960

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

38.9

307.7

402

A28

ICPC

Limited function/disability NOS

2.7

307.7

4137

17088

N05BA04

ATC

oxazepam; oral

2.3

307.7

3586

15894

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

9.3

307.7

710

679

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

122.2

307.7

1443

114

G30.0

ICD-10 Finland

Alzheimer disease with early onset

283.3

307.7

575

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

137.5

307.7

455

F06.7

ICD-10 Finland

Mild cognitive disorder

4.5

307.7

948

1910

P20

ICPC

Memory disturbance

6.8

307.7

5444

11638

N06DA02

ATC

donepezil; oral

42.5

307.7

5619

2200

G30

ICD-10 Finland

Alzheimer disease

53.1

307.7

901

155

F03

ICD-10 Finland

Unspecified dementia

5.7

307.7

2082

3615

SPAT1053

SPAT

Memory test

3.3

307.7

4070

14108

WYA20

NOMESCO Finland

Home visit

6.6

307.7

641

854

N06DA03

ATC

rivastigmine; oral, transdermal

25.2

307.7

3495

1670

R41.3

ICD-10 Finland

Other amnesia

6.1

307.7

1039

1552

G30.1

ICD-10 Finland

Alzheimer disease with late onset

400.7

307.7

9303

1189

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

84.9

307.7

4203

665

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

86.0

307.7

4392

705

N05AH04

ATC

quetiapine; oral

4.3

307.7

2600

6149

N06DX01

ATC

memantine; oral

63.3

307.7

7326

2775

F0019, G301,

ICD-10 Finland

7209.8

307.7

805

N05AX08

ATC

risperidone; systemic

10.1

307.7

3451

3980

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

172.0

307.7

3165

216

G30.8

ICD-10 Finland

Other Alzheimer disease

31.2

307.7

1093

326

N06DA04

ATC

galantamine; oral

14.7

307.7

1452

945

F05.1

ICD-10 Finland

Delirium superimposed on dementia

11.2

298.0

348

269

F001, G301,

ICD-10 Finland

135.1

294.7

174

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.3

275.4

1211

3367

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

135.6

269.3

159

R53

ICD-10 Finland

Malaise and fatigue

2.1

268.6

3511

16572

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

14.3

254.6

257

154

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

93.2

250.6

153

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

105.8

247.2

149

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

240.8

4715

25538

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.4

228.5

490

787

N06AX11

ATC

mirtazapine; oral

2.0

226.0

3861

19846

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

214.1

1873

7406

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

205.3

2742

12830

N05AH03

ATC

olanzapine; systemic

4.1

204.0

612

1303

SPAT1216

SPAT

Assessment of functional ability

2.0

201.4

2834

13501

N03AG01

ATC

valproic acid; systemic, rectal

3.6

198.8

726

1779

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

188.5

1515

5743

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

188.4

1015

3151

SPAT1234

SPAT

Support of social functional capacity

2.7

183.7

1133

3778

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

179.3

787

2168

TAB00

NOMESCO Finland

Lumbar puncture

4.3

176.1

498

1012

F0009, G300,

ICD-10 Finland

+∞

172.9

177

N06AB10

ATC

escitalopram; oral

2.3

172.4

1580

6329

F0014, G301,

ICD-10 Finland

370.0

162.5

174

Z75.5

ICD-10 Finland

Holiday relief care

5.4

157.9

340

547

F00

ICD-10 Finland

Dementia in Alzheimer disease

14.3

157.6

159

N06AX26

ATC

vortioxetine; oral

3.4

154.5

612

1578

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

146.0

3216

17417

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

60.7

144.0

N02AA05

ATC

oxycodone; systemic

1.8

142.7

2823

14789

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

138.7

864

2881

N02BE01

ATC

paracetamol; systemic, rectal

1.9

133.6

9267

67754

N05AD01

ATC

haloperidol; systemic

3.0

129.5

626

1819

A04

ICPC

Weakness/tiredness general

1.9

126.3

2048

10032

AA1AD

NOMESCO Finland

CT of head and brain

1.6

121.0

3798

22402

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

116.9

4164

25289

SPAT1254

SPAT

Administration of medicine

1.8

116.2

2246

11582

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

113.4

1315

5720

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

112.7

975

3775

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.0

105.7

326

706

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

104.1

2393

12913

A06AD11

ATC

lactulose; oral

1.7

103.6

2633

14593

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

96.6

650

2242

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

95.7

766

2861

XA800

NOMESCO Finland

Neuropsychological investigation

3.7

94.8

326

763

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

92.8

2072

11048

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

92.2

2192

11885

L28

ICPC

Limited function/disability (L)

1.6

90.9

2710

15557

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

89.9

1730

22547

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

87.7

695

2583

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.6

87.0

310

743

N06AB04

ATC

citalopram; systemic

1.7

86.4

2124

11594

U04

ICPC

Incontinence urine

2.1

86.1

888

3679

S01.0

ICD-10 Finland

Open wound of scalp

2.0

83.5

1077

4839

R55

ICD-10 Finland

Syncope and collapse

1.7

81.4

1679

8726

SPAT1360

SPAT

Extensive global examination

2.0

79.9

973

4283

F0011, G301,

ICD-10 Finland

186.5

79.6

130

Kela drug reimbursment

Malignant tumour

0.3

77.7

270

6643

S06.0

ICD-10 Finland

Concussion

1.9

76.4

1173

5576

AXX01, ,

SPAT

2.5

74.5

498

1710

F0029, G308,

ICD-10 Finland

+∞

74.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

73.7

1297

17483

J01CA08

ATC

pivmecillinam; oral

1.5

70.7

3857

24945

N06AB06

ATC

sertraline; oral

2.1

68.5

757

3210

F21, ,

ICPC

3.8

66.9

220

499

N07AA05, ,

ATC

582.9

65.5

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

64.5

739

3174

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

64.2

1546

8332

SPAT1101

SPAT

Orthostatic test

2.0

62.4

788

3502

F05.9

ICD-10 Finland

Delirium, unspecified

2.5

60.9

410

1411

N30.0

ICD-10 Finland

Acute cystitis

1.6

60.8

1836

10441

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.8

59.9

925

4392

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.2

59.5

167

337

SPAT1252

SPAT

Overall medication plan or its review

1.8

58.3

984

4798

W19

ICD-10 Finland

Unspecified fall

1.7

57.6

1179

6074

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

82.2

57.3

H02AB02

ATC

dexamethasone; systemic

0.4

55.9

291

5983

Z29

ICPC

Social problem NOS

2.9

55.2

267

774

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

54.4

516

8448

N05AD03

ATC

melperone; systemic

3.0

54.0

250

707

A29

ICPC

General symptom/complaint other

1.6

53.5

1487

8270

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

52.1

776

3637

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

51.4

743

3450

R42

ICD-10 Finland

Dizziness and giddiness

1.4

51.1

2850

18261

S70.0

ICD-10 Finland

Contusion of hip

2.0

50.4

567

2416

LAITO, ,

NOMESCO Finland

11.5

50.1

F0012, G301,

ICD-10 Finland

446.5

50.0

SPAT1139

SPAT

Nutrition survey

2.2

49.8

456

1796

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

49.3

1151

6125

J01DB01

ATC

cefalexin; oral

1.4

47.9

7582

57086

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

47.5

391

1473

R5110, ,

SPAT

1.8

46.9

843

4177

SPAT1153

SPAT

Removal of sutures

0.7

46.9

1946

22090

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

67.7

46.2

J01EA01

ATC

trimethoprim; systemic

1.4

45.0

2992

19673

E86

ICD-10 Finland

Volume depletion

2.2

44.7

422

1682

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

44.4

1528

8888

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

44.2

376

1436

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.2

43.7

187

505

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.1

43.7

192

527

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

42.8

1099

13778

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

42.7

656

3101

SPAT1301

SPAT

No procedures

1.3

42.0

3433

23266

SPAT1172

SPAT

Guidance concerning hydration

2.0

39.7

439

1857

SPAT1251

SPAT

Organisation of medication

1.9

39.6

515

2306

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

39.5

1967

21763

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

181.5

39.0

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

95.0

38.7

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

38.4

208

642

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

38.2

445

1918

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

38.1

1565

9410

F0013, G301,

ICD-10 Finland

+∞

37.0

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.5

36.8

246

844

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.4

36.8

136

335

SPAT1229

SPAT

Assessment of need for aid

1.5

36.2

1093

6161

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

36.2

863

4603

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

36.0

3957

27813

AXX01

NOMESCO Finland

Memory assessment

8.3

36.0

WZC30

NOMESCO Finland

Teaching

0.6

35.9

577

8130

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.2

35.7

317

1233

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

35.5

1263

7374

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

11.8

34.8

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

34.5

722

3725

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

34.2

495

2294

EB1VA, ,

NOMESCO Finland

0.4

33.3

176

3615

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.5

33.1

217

738

AA1AD, ,

SPAT

6.3

32.4

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

32.3

426

1916

-2, ,

ICPC

3.5

31.9

117

287

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

31.9

1069

6157

WX402

NOMESCO Finland

General anaesthesia

0.6

31.7

634

8469

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

30.9

293

1171

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

30.7

504

2428

U13

ICPC

Bladder symptom/complaint other

2.0

30.3

347

1487

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

29.9

1902

A04AA02

ATC

granisetron; systemic, transdermal

0.3

29.9

113

2699

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

29.5

728

3911

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

29.3

943

5383

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

29.2

KMAK, ,

NOMESCO Finland

1.3

28.6

3299

23154

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.0

28.5

184

C10AA01

ATC

simvastatin; oral

1.3

28.5

5623

42044

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

28.5

399

5855

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

28.4

520

2586

JN4AD

NOMESCO Finland

Body CT examination

0.6

27.9

439

6244

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

27.6

309

1314

F009, G301,

ICD-10 Finland

+∞

27.3

F22.0

ICD-10 Finland

Delusional disorder

2.7

26.9

154

491

WZC00

NOMESCO Finland

Treatment plan or consultation

0.7

26.9

1830

19509

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

26.7

871

10499

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

26.7

998

11722

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

26.6

341

1520

F0024, G301,

ICD-10 Finland

+∞

26.3

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

6.4

25.7

Z2445

NOMESCO Finland

Psychologist

2.5

25.6

160

533

M04AA01

ATC

allopurinol; systemic

0.7

25.3

1114

12724

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.9

25.0

306

1344

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

9.0

24.7

Z28

ICPC

Limited function/disability (Z)

3.5

24.6

217

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

24.6

428

5935

A04AA01

ATC

ondansetron; systemic, rectal

0.5

24.6

226

3775

C03DA01

ATC

spironolactone; oral

0.7

24.3

932

10914

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

24.3

1837

E0000UV, ,

ATC

1.2

24.2

3537

25418

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.3

23.6

185

684

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

23.6

128

2604

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

23.5

1453

A10AB05

ATC

insulin aspart; parenteral

1.5

23.5

734

4158

N07AA06, ,

ATC

+∞

23.4

SPAT1050

SPAT

Extensive neurological examination

2.1

23.3

239

986

C10AX09

ATC

ezetimibe; oral

0.7

23.2

677

8356

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

23.2

269

1160

N28

ICPC

Limited function/disability (N)

2.2

23.1

197

755

OAB76

NOMESCO Finland

General guidance on nutrition and food

8.4

22.9

N27

ICPC

Fear of neurological disease other

2.2

22.7

201

783

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

6.2

22.6

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

22.5

325

1507

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

22.5

655

8088

H02AB06

ATC

prednisolone; systemic

0.8

22.0

3649

35136

A10BK03

ATC

empagliflozin; oral

0.6

21.9

318

4630

W0A10

NOMESCO Finland

Mapping of psychosocial situation

6.9

21.9

A98

ICPC

Health maint/preventive medicine

1.2

21.6

8235

65084

F0024, G308,

ICD-10 Finland

+∞

21.4

F0019, G309,

ICD-10 Finland

+∞

21.4

A23

ICPC

Risk factor NOS

1.6

21.3

457

2370

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.6

21.3

176

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

21.2

1962

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.9

21.1

280

1264

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.4

20.8

187

N02AX02

ATC

tramadol; systemic, rectal

0.8

20.7

3198

31080

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.5

20.6

180

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

20.5

951

5812

P05

ICPC

Senility, feeling/behaving old

2.8

20.0

105

321

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

19.7

1896

N17

ICPC

Vertigo/dizziness

1.3

19.7

1314

8511

F05.8

ICD-10 Finland

Other delirium

2.6

19.7

114

367

R06.0

ICD-10 Finland

Dyspnoea

0.8

19.4

2109

21336

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

19.3

127

435

I67.4

ICD-10 Finland

Hypertensive encephalopathy

7.1

19.3

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

19.3

250

3755

Z51.5

ICD-10 Finland

Palliative care

1.4

19.2

1046

6566

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

19.0

779

9045

F32

ICD-10 Finland

Depressive episode

1.9

19.0

245

1096

ZXA00

NOMESCO Finland

Right side

1.2

19.0

2870

20582

D12

ICPC

Constipation

1.6

18.7

418

2191

P29

ICPC

Psychological sympt/compl other

1.9

18.7

228

1002

P04

ICPC

Feeling/behaving irritable/angry

5.1

18.6

SPAT1284

SPAT

Extensive health certificate

2.0

18.6

206

875

ZXD35

NOMESCO Finland

Usual procedure

1.7

18.5

322

1580

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

18.8

18.5

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

18.3

237

1062

T03

ICPC

Loss of appetite

3.7

18.2

134

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.0

18.2

226

ICB01, ,

SPAT

4.0

18.2

115

C10AA07

ATC

rosuvastatin; oral

0.8

18.1

1753

17999

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.6

18.1

103

329

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.1

18.0

918

SPAT1058

SPAT

PEF monitoring instruction

0.6

17.9

305

4258

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

17.9

462

5856

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

17.7

1992

20114

L01BC06

ATC

capecitabine; oral

0.4

17.7

1756

E000001, ,

ATC

1.3

17.6

1608

10863

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

17.6

828

Z60.8

ICD-10 Finland

Other problems related to social environment

3.8

17.5

126

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.0

17.5

183

762

F009, F03,

ICD-10 Finland

8.1

17.4

G04CB01

ATC

finasteride; oral

1.3

17.3

1736

11864

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.1

17.3

159

630

Z51.88

ICD-10 Finland

Other specified medical care

1.9

17.2

205

895

WYA30, ,

SPAT

3.3

17.1

169

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.3

17.0

EB4VA, ,

NOMESCO Finland

0.4

16.8

1776

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

16.7

522

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

16.7

1453

15132

SPAT1167

SPAT

Insertion of urinary catheter

1.5

16.5

464

2570

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

16.3

16.4

WX199

NOMESCO Finland

Other local analgesia

0.4

16.3

104

1976

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

16.3

1810

12517

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

16.1

462

2569

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

16.1

1174

7691

R33

ICD-10 Finland

Retention of urine

1.3

16.1

1122

7307

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

16.0

433

5441

Z03

ICPC

Housing/neighbourhood problem

2.9

16.0

234

ZXY02

NOMESCO Finland

Neuropsychologist

5.1

15.9

A27

ICPC

Fear of other disease NOS

1.5

15.9

460

2563

D07AA02

ATC

hydrocortisone; topical

1.3

15.8

1024

6597

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

15.7

1762

J01MA02

ATC

ciprofloxacin; systemic

1.2

15.7

4037

30324

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

17.6

15.6

F0022, G308,

ICD-10 Finland

+∞

15.6

W06

ICD-10 Finland

Fall involving bed

2.2

15.6

127

480

WW500

NOMESCO Finland

Blood transfusion

0.5

15.6

133

2275

Y94.1

ICD-10 Finland

Accident in connection with service housing

6.2

15.6

R11

ICD-10 Finland

Nausea and vomiting

1.4

15.5

809

5038

I50.1

ICD-10 Finland

Left ventricular failure

0.6

15.4

387

4936

L75

ICPC

Fracture: femur

1.9

15.4

193

858

TQW40, ,

SPAT

0.5

15.2

187

2849

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

15.1

977

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

15.1

487

5908

Y94.0

ICD-10 Finland

Accident at home

1.8

15.1

209

960

N03AX14

ATC

levetiracetam; systemic

1.8

15.0

221

1035

XF606, ,

SPAT

2.8

14.9

234

HA1RA, ,

SPAT

0.2

14.9

981

R54

ICD-10 Finland

Senility

2.4

14.8

106

379

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

14.8

1204

12663

L15

ICPC

Knee symptom/complaint

0.8

14.8

1249

13075

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

14.7

931

5973

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.9

14.7

174

758

S01

ICD-10 Finland

Open wound of head

2.2

14.7

129

503

R03AC02

ATC

salbutamol; inhalant

0.8

14.7

3567

33560

N06AX21

ATC

duloxetine; oral

1.4

14.6

702

4312

SPAT1014

SPAT

Treatment of eyes

1.8

14.5

219

1032

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

14.5

451

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

14.5

2605

18914

ZXA05

NOMESCO Finland

Left side

1.2

14.5

2668

19419

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

14.3

1722

11999

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

14.2

498

2888

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

14.2

257

1278

Z75.0

ICD-10 Finland

Medical services not available in home

3.5

14.1

121

L08

ICPC

Shoulder symptom/complaint

0.8

14.1

1093

11577

C04AE01

ATC

ergoloid mesylates; systemic

2.2

14.0

119

458

XF606

NOMESCO Finland

Ortostatic test

2.4

14.0

347

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

14.0

1385

9433

S18

ICPC

Laceration/cut

0.8

14.0

3395

31985

WF002

NOMESCO Finland

Radical radiotherapy

0.6

13.9

195

2865

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

13.9

146

610

F00, F03,

ICD-10 Finland

5.3

13.8

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

13.5

1287

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

67.4

13.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

13.5

1397

9566

F0021, G301,

ICD-10 Finland

126.3

13.4

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

13.4

1008

10716

A10BK01

ATC

dapagliflozin; oral

0.6

13.3

234

3241

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

13.3

857

5513

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

13.3

867

5590

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.9

13.2

163

721

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

13.2

141

2238

S28

ICPC

Limited function/disability (S)

2.4

13.1

301

IHZ08, ,

SPAT

4.5

13.1

R2110

NOMESCO Finland

Giving the first information

1.5

13.0

418

2382

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

13.0

604

3688

G04CA02

ATC

tamsulosin; oral

1.2

13.0

3153

23470

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

13.0

4356

33280

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

12.9

718

4517

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

12.8

621

3823

N06AX16

ATC

venlafaxine; oral

1.4

12.7

617

3797

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

12.7

213

2983

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

12.7

188

883

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

12.7

135

568

K08.3

ICD-10 Finland

Retained dental root

1.4

12.6

602

3695

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.7

12.5

253

1297

G04BD08

ATC

solifenacin; oral

1.3

12.5

747

4752

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

12.5

141

606

G03CA04

ATC

estriol; systemic, vaginal

1.3

12.5

982

6495

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

12.4

361

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.5

12.4

258

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

12.3

178

2592

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

12.3

461

2710

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

12.3

1316

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

12.3

2069

14902

L13

ICPC

Hip symptom/complaint

0.8

12.2

1163

12030

Z2221

NOMESCO Finland

Medical doctor

1.2

12.2

2309

16812

Z11

ICPC

Compliance/being ill problem

2.6

12.1

241

TK800

NOMESCO Finland

Hemodialysis

0.3

12.1

883

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.6

12.1

232

H02AA02

ATC

fludrocortisone; oral

2.1

12.0

111

444

T05

ICPC

Feeding problem of adult

2.8

11.9

176

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

11.9

284

1517

K59.0

ICD-10 Finland

Constipation

1.4

11.9

635

3969

R45.1

ICD-10 Finland

Restlessness and agitation

4.2

11.9

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

11.9

206

1013

M02AA07

ATC

piroxicam; topical

1.2

11.9

3606

27288

JN4BD

NOMESCO Finland

Extensive body CT

0.7

11.9

627

7007

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

3.7

11.9

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

11.7

164

F0001, G300,

ICD-10 Finland

+∞

11.7

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

11.7

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

11.7

354

4347

N05AX12

ATC

aripiprazole; systemic

2.5

11.7

256

A01

ICPC

Pain general/multiple sites

1.3

11.6

807

5246

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

5.0

11.6

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

11.6

1494

10472

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

11.6

1161

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

11.5

201

2786

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

11.5

146

653

N02BF01

ATC

gabapentin; oral

0.6

11.5

264

3432

B01AB10

ATC

tinzaparin; parenteral

0.7

11.5

428

5059

R1250, ,

SPAT

1.9

11.4

147

661

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

11.4

186

2619

A10BJ06

ATC

semaglutide; parenteral

0.4

11.4

1017

K86

ICPC

Hypertension uncomplicated

0.8

11.3

887

9395

XA400

NOMESCO Finland

EEG

2.8

11.3

177

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

3.3

11.2

106

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

31.6

11.2

ZX120

NOMESCO Finland

Intravenous

0.7

11.2

477

5514

XCH00

NOMESCO Finland

Eye pressure measurement

0.6

11.1

224

2999

L57.0

ICD-10 Finland

Actinic keratosis

0.8

11.1

962

10064

ZXD20

NOMESCO Finland

Day surgery

1.3

11.1

985

6616

P28

ICPC

Limited function/disability (P)

2.8

11.1

160

S82

ICPC

Naevus/mole

0.7

11.0

566

6355

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.6

11.0

213

A78

ICPC

Infectious disease other/NOS

2.2

11.0

354

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

10.9

304

3794

T08

ICPC

Weight loss

1.8

10.8

149

686

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.2

10.8

109

A11CC03

ATC

alfacalcidol; systemic

0.4

10.7

1278

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

10.7

562

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

10.7

300

1664

R4110, ,

SPAT

0.7

10.7

332

4058

A10AE04

ATC

insulin glargine; parenteral

1.3

10.7

854

5659

TPH07

NOMESCO Finland

Cathetrisation of artery

0.8

10.6

693

7518

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

10.6

2840

21243

N05CD07

ATC

temazepam; oral

1.2

10.6

1541

10926

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

2.8

10.6

155

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

10.6

599

AA1CG, ,

SPAT

2.5

10.5

218

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

10.5

1123

N07

ICPC

Convulsion/seizure

4.7

10.4

TDA90, ,

SPAT

0.6

10.4

206

2767

N30

ICD-10 Finland

Cystitis

1.4

10.4

579

3646

A12AA04

ATC

calcium carbonate; oral

0.3

10.4

809

SPAT1043

SPAT

Audiometry

0.8

10.2

783

8318

WZC30, ,

SPAT

0.6

10.2

166

2336

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

10.2

1019

6943

L01CA04

ATC

vinorelbine; systemic

0.2

10.2

367

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

10.1

1388

SPAT1312

SPAT

General health counselling

0.8

10.1

1936

18718

R03BB04

ATC

tiotropium bromide; inhalant

0.8

10.1

820

8652

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.6

10.1

245

3145

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

10.1

623

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

10.0

1114

A05

ICPC

Feeling ill

1.5

10.0

315

1792

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.4

10.0

224

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.2

10.0

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

10.0

699

U28

ICPC

Limited function/disability (U)

1.9

9.9

131

595

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.3

9.9

738

N43

ICPC

Neurological, Other diagnostic procedure

2.6

9.9

190

G72.8

ICD-10 Finland

Other specified myopathies

1.7

9.9

180

900

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.8

9.8

152

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

50.5

9.8

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

9.8

290

1629

R45.5

ICD-10 Finland

Hostility

9.4

9.8

S32.5

ICD-10 Finland

Fracture of pubis

1.9

9.7

126

569

F0010, G308,

ICD-10 Finland

+∞

9.7

F0004, G300,

ICD-10 Finland

+∞

9.7

F0021, G308,

ICD-10 Finland

+∞

9.7

F0009, G309,

ICD-10 Finland

+∞

9.7

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

9.7

1502

EBA00

NOMESCO Finland

Extraction of tooth

1.2

9.7

2354

17451

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

9.7

721

7691

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

18.0

9.7

F0001, G301,

ICD-10 Finland

92.6

9.7

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

9.6

1305

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

9.6

126

R01AD58

ATC

fluticasone, combinations; nasal

0.8

9.6

585

6405

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

9.6

379

2254

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.5

9.6

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

2.3

9.6

281

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

9.5

876

5908

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.1

9.5

3476

26559

N18.8

ICD-10 Finland

Other chronic renal failure

0.6

9.5

126

1870

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.5

348

4122

E66.01

ICD-10 Finland

Obesity due to excess calories

0.5

9.5

112

1718

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

9.4

174

873

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

9.4

1464

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

9.4

1062

-, ,

ICD-10 Finland

1.6

9.4

212

1120

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.7

9.4

161

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

9.4

443

2719

R03BA08

ATC

ciclesonide; inhalant

0.7

9.3

266

3303

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

9.3

276

1551

DFF00

NOMESCO Finland

Pure tone audiometry

0.8

9.3

588

6409

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.6

9.3

217

1156

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

9.3

912

Z08

ICPC

Social welfare problem

2.2

9.3

318

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.4

9.2

1100

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

9.2

247

1359

N05AB03

ATC

perphenazine; systemic, rectal

1.6

9.2

199

1042

L03AA02

ATC

filgrastim; parenteral

0.5

9.1

1153

WYA20, ,

SPAT

2.5

9.1

188

N99

ICPC

Neurological disease other

2.0

9.1

422

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.4

9.1

SPAT1236

SPAT

Informing family of child’s disability

1.7

9.1

172

870

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

3.8

9.1

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

9.0

752

G47.3

ICD-10 Finland

Sleep apnoea

0.8

9.0

839

8715

L03AA13

ATC

pegfilgrastim; parenteral

0.5

9.0

1465

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

9.0

1177

8250

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

9.0

1464

10487

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.5

8.9

272

1538

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.9

8.9

4077

37078

G04BD07

ATC

tolterodine; oral

1.3

8.9

600

3887

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

8.9

783

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

8.8

1276

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

8.8

161

2197

F0023, G308,

ICD-10 Finland

84.2

8.7

F0014, G309,

ICD-10 Finland

84.2

8.7

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

4.3

8.7

C09CA06

ATC

candesartan; oral

0.8

8.7

1385

13626

S15

ICPC

Foreign body in skin

0.7

8.7

254

3138

L90

ICPC

Osteoarthrosis of knee

0.7

8.7

328

3865

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

8.7

467

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

4.1

8.7

AA1AA

NOMESCO Finland

Head X-ray examination

2.1

8.6

322

RD211, ,

NOMESCO Finland

0.6

8.6

124

1798

Z74.1

ICD-10 Finland

Need for assistance with personal care

8.0

8.6

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.5

8.5

245

1369

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.5

560

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

8.5

1399

13724

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.7

8.5

387

4423

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

9.5

8.5

SPAT1059

SPAT

Spirometry at the office

0.6

8.5

200

2579

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.1

8.5

XQ855, ,

SPAT

2.2

8.4

275

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.6

8.4

173

895

IHA10, ,

SPAT

2.4

8.4

206

L89

ICPC

Osteoarthrosis of hip

0.6

8.3

149

2045

250, ,

Kela drug reimbursment

0.3

8.3

657

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

4.8

8.3

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.8

8.3

114

527

N05CF01

ATC

zopiclone; oral

1.1

8.2

3484

26819

R4110

NOMESCO Finland

Physiotherapy

1.2

8.2

2334

17485

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

8.2

839

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

8.2

742

7732

HMAK, ,

NOMESCO Finland

0.7

8.2

356

4099

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.1

8.2

2756

20895

L03

ICPC

Low back symptom/complaint

0.8

8.2

1484

14441

R4135

NOMESCO Finland

Rehabilitation for hearing problems

0.5

8.2

1483

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

8.1

353

2137

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

4.6

8.1

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.7

8.1

400

4514

A01AB09

ATC

miconazole; local oral

1.3

8.1

824

5625

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

8.1

600

3940

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

2.8

8.1

125

OAA67, ,

SPAT

1.9

8.1

400

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

8.0

4532

35494

SPAT1111

SPAT

Planning of analgesia

1.8

8.0

109

502

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

8.0

236

2908

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

8.0

217

2718

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

0.7

8.0

254

3086

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

8.0

841

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

8.0

571

3731

S22.3

ICD-10 Finland

Fracture of rib

1.3

8.0

578

3783

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.7

7.9

131

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.8

7.9

125

602

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

7.9

232

1303

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.3

7.9

217

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

7.9

1228

N04BD02

ATC

rasagiline; oral

0.2

7.9

348

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

7.9

348

L86

ICPC

Back syndrome with radiating pain

0.7

7.9

221

2748

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

7.9

143

717

J01CA04

ATC

amoxicillin; systemic

1.1

7.8

6738

54041

L03AA14

ATC

lipegfilgrastim; parenteral

0.2

7.8

477

I95.9

ICD-10 Finland

Hypotension, unspecified

1.6

7.8

166

866

C02AC05

ATC

moxonidine; oral

0.7

7.8

248

3014

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.7

7.8

126

611

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.4

7.8

182

F009, G308,

ICD-10 Finland

75.8

7.8

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.1

7.8

273

R06AE07

ATC

cetirizine; oral

1.1

7.8

2982

22791

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.5

7.8

1121

F000, G300,

ICD-10 Finland

+∞

7.8

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.8

854

R03DA04

ATC

theophylline; systemic, rectal

0.8

7.8

491

5347

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

0.6

7.7

1449

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

0.6

7.7

141

1925

SPAT1125

SPAT

Stoma care and guidance

1.5

7.7

212

1175

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

7.7

1140

S21

ICPC

Skin texture symptom/complaint

0.8

7.7

828

8465

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

7.7

4339

33960

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

9.7

7.6

A04AA55

ATC

palonosetron, combinations; systemic

0.3

7.6

627

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

7.6

454

I50.0

ICD-10 Finland

Congestive heart failure

0.8

7.6

970

9747

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

7.6

494

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.7

7.6

120

Z3226

NOMESCO Finland

Physiotherapist

1.2

7.6

1556

11365

A10AE05

ATC

insulin detemir; parenteral

1.4

7.6

413

2597

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.1

7.5

248

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.7

7.5

142

720

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.9

7.5

102

SPAT1377

SPAT

Polysomnography

0.4

7.5

853

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

7.5

814

8313

M05BA07

ATC

risedronic acid; oral

1.4

7.5

380

2363

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

10.7

7.5

F32.0

ICD-10 Finland

Mild depressive episode

1.8

7.5

112

532

T11

ICPC

Dehydration

3.6

7.5

HA1AA, ,

SPAT

0.3

7.5

516

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.6

7.4

1453

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

7.4

277

1634

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.7

7.4

132

659

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.6

7.4

141

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

2.7

7.4

117

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

7.4

740

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

7.4

1166

N29

ICPC

Neurological sympt/complt other

1.6

7.4

153

795

M02AA15

ATC

diclofenac; topical

1.3

7.4

574

3795

N18.0

ICD-10 Finland

End-stage renal disease

0.4

7.3

640

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.8

7.3

620

6511

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.3

7.3

465

2990

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.6

7.3

169

901

S16

ICPC

Bruise/contusion

1.4

7.3

301

1807

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

7.3

821

S06.3

ICD-10 Finland

Focal brain injury

1.7

7.3

116

561

WX722

NOMESCO Finland

PEEP

0.7

7.3

178

2275

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.2

7.3

441

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

7.3

181

2304

SPAT1285

SPAT

Provision of consultation response

1.3

7.3

429

2730

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

7.2

869

6041

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.5

7.2

158

UDC00

NOMESCO Finland

Ear microscopy

0.7

7.2

345

3909

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.6

7.2

123

1704

N05AL01

ATC

sulpiride; systemic

1.8

7.2

109

520

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.7

7.2

209

2579

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.7

7.2

120

589

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

7.2

201

2497

R02

ICPC

Shortness of breath/dyspnoea

0.8

7.1

881

8884

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

7.1

101

1468

Z71.8

ICD-10 Finland

Other specified counselling

1.2

7.1

2008

15019

TFP20

NOMESCO Finland

Cardiodefibrillation

0.8

7.1

505

5418

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

7.1

679

4601

F0022, G301,

ICD-10 Finland

37.9

7.1

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

7.1

301

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

7.1

786

5419

PD5AD

NOMESCO Finland

CT of aorta

0.5

7.1

1127

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

7.1

701

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

7.1

865

8727

P71

ICPC

Organic psychosis other

10.9

7.1

137

Kela drug reimbursment

Uraemia requiring dialysis

0.2

7.0

275

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

0.3

7.0

458

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

7.0

308

XQ848

NOMESCO Finland

Dermatological photography

0.6

7.0

106

1513

Z49.2

ICD-10 Finland

Other dialysis

0.1

7.0

197

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.4

7.0

612

207

Kela drug reimbursment

Chronic arrhythmias

0.9

7.0

1747

16593

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

7.0

1292

9355

C08CA13

ATC

lercanidipine; oral

0.8

7.0

1133

11135

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

7.0

299

3444

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.0

7.0

176

Y94.8

ICD-10 Finland

Other leisure activity accident

1.6

6.9

176

960

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.9

460

2978

R44.0

ICD-10 Finland

Auditory hallucinations

2.5

6.9

136

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

6.9

232

2787

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

0.6

6.9

162

2086

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

6.9

1346

13031

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

0.6

6.9

131

1768

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

6.9

455

2946

R18

ICD-10 Finland

Ascites

0.5

6.8

959

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

0.1

6.8

194

SDA03

NOMESCO Finland

Periodontal treatment

0.9

6.8

1603

15297

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

6.8

1131

8112

H13

ICPC

Plugged feeling ear

0.9

6.8

1527

14622

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.0

6.8

306

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.7

6.8

211

2569

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.7

6.8

110

536

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

6.8

644

4364

C01AA05

ATC

digoxin; systemic

0.8

6.8

1122

11010

C10AA02

ATC

lovastatin; oral

1.3

6.7

553

3681

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.6

6.7

1317

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.7

6.7

306

3493

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

6.7

507

3339

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

6.7

230

Z51.0

ICD-10 Finland

Radiotherapy session

0.4

6.7

612

D11

ICPC

Diarrhoea

1.3

6.7

620

4188

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

6.7

210

2553

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.6

6.7

105

1484

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

6.7

1019

7250

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

6.7

779

D10

ICPC

Vomiting

1.5

6.7

176

969

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.7

6.6

301

3437

P19

ICPC

Drug abuse

3.4

6.6

J01MA06

ATC

norfloxacin; oral

1.2

6.6

1190

8597

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.4

6.6

606

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.6

6.6

108

1508

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

6.6

150

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.8

6.6

414

4507

T93

ICPC

Lipid disorder

0.7

6.6

274

3169

R96

ICPC

Asthma

0.8

6.6

438

4733

P18

ICPC

Medication abuse

2.8

6.6

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.8

6.5

391

4288

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.4

6.5

748

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

6.5

114

1567

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

6.5

142

749

F34.1

ICD-10 Finland

Dysthymia

1.6

6.5

128

658

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.2

6.5

1112

7997

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

6.5

1129

XX2RW, ,

NOMESCO Finland

0.2

6.5

308

L02BG06

ATC

exemestane; oral

0.4

6.4

588

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

3.9

6.4

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

6.4

272

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

6.4

274

1659

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

0.0

6.4

136

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.4

6.4

261

1568

S01EX03, ,

ATC

1.4

6.4

317

1968

SPAT1263

SPAT

Sampling

1.1

6.4

3626

28307

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

0.4

6.4

693

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.8

6.4

434

SPAT1244

SPAT

Occupational therapy

1.8

6.3

428

Z01.7

ICD-10 Finland

Laboratory examination

1.2

6.3

978

6967

ZY000

NOMESCO Finland

Hospital inpatient

2.3

6.3

163

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.3

6.3

508

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

6.3

442

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

0.4

6.3

557

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

6.3

168

2105

R26

ICD-10 Finland

Abnormalities of gait and mobility

2.7

6.3

103

D82

ICPC

Teeth/gum disease

0.9

6.3

1428

13670

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

6.3

1099

7917

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

6.3

1107

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.7

6.3

109

542

115

Kela drug reimbursment

Breast cancer

0.8

6.3

360

3969

SPAT1042

SPAT

Guidance concerning balance maintenance

2.0

6.3

263

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

6.3

1289

M01AH05

ATC

etoricoxib; oral

0.9

6.2

3391

30722

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

6.2

504

D07AB08

ATC

desonide; topical

1.2

6.2

809

5670

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.2

1439

10605

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

6.2

551

3707

S20.2

ICD-10 Finland

Contusion of thorax

1.3

6.2

364

2319

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.2

6.2

181

R01AD12

ATC

fluticasone furoate; nasal

0.8

6.1

1003

9858

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

0.1

6.1

180

128

Kela drug reimbursment

Cancers of female genital organs

0.4

6.1

706

SCF02

NOMESCO Finland

Preventive oral care by dental hygienist

1.6

6.1

146

787

R40.2

ICD-10 Finland

Coma, unspecified

1.8

6.1

415

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.0

6.1

266

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

6.1

393

F0020, G301,

ICD-10 Finland

18.9

6.1

K05.30

ICD-10 Finland

Periodontitis complex

0.8

6.1

617

6346

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

6.1

1288

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

6.1

444

4739

SPAT1016

SPAT

Examination of vision

0.7

6.0

199

2395

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.5

6.0

200

1156

D06BB10

ATC

imiquimod; topical

0.7

6.0

259

2981

193

Kela drug reimbursment

Rasagiline

0.2

6.0

265

S01BC05

ATC

ketorolac; ophthalmic

1.3

6.0

522

3500

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

0.7

6.0

234

2736

S42.0

ICD-10 Finland

Fracture of clavicle

1.5

6.0

175

986

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.3

6.0

403

A69.2

ICD-10 Finland

Lyme disease

0.7

6.0

183

2233

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

4187

19587

2.28

307.65

1.9

1.8

1196.69

1157.05

nmol/l

1.77

2967

14369

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

476

287

14.53

307.65

1.0

429.72

275.99

ng/l

13.83

348

162

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

480

287

14.66

307.65

1.0

57.30

36.40

ng/l

11.95

348

161

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

480

288

14.60

307.65

1.0

566.34

731.19

ng/l

6.83

344

155

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3300

16230

2.01

217.32

3.1

3.0

2.46

2.47

mmol/l

9.09

2892

13787

(3015377) Calcium [Moles/volume] in Serum or Plasma

4589

26585

1.77

171.64

2.6

3.2

2.35

mmol/l

0.89

3910

22275

(3021960) Folate [Moles/volume] in Serum or Plasma

3840

21146

1.81

170.20

1.7

1.6

20.62

20.13

nmol/l

0.86

3413

17635

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5637

34754

1.74

168.26

2.5

2.2

90.74

92.59

pmol/l

2.09

2894

17731

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

476

1088

3.80

143.47

1.2

1.3

483.00

607.68

mg/l

3.19

415

1030

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

421

913

3.99

136.38

1.3

1.4

351.71

1266.57

e6/l

2.57

322

767

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

420

913

3.98

135.61

1.2

1.3

6.76

22.80

e6/l

1.47

315

726

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

424

941

3.90

133.07

1.2

3.82

3.92

mmol/l

1.01

389

866

(3044290) Cell count panel - Cerebral spinal fluid

386

854

3.90

121.59

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

7085

49002

1.60

112.67

6.2

5.7

3044.00

1565.19

e6/l

1.18

209

832

(3009466) Valproate [Moles/volume] in Serum or Plasma

306

636

4.13

104.76

3.0

3.4

309.62

322.36

umol/l

0.69

243

504

(3023410) Appearance of Cerebral spinal fluid

220

364

5.17

99.01

1.3

1.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5261

34653

1.53

97.64

3.7

4.4

34.41

33.86

g/l

10.08

4708

31515

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1918

10314

1.68

82.13

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1912

10367

1.67

79.02

1.9

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3961

25367

1.49

78.54

2.5

2.1

—

(3003338) MCHC [Mass/volume]

6630

46943

1.47

78.16

26.8

27.1

329.50

329.86

g/l

2.41

6448

46254

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4319

28319

1.46

74.98

2.1

2.2

77.96

81.15

nmol/l

9.16

3682

24002

(3026008) Bacteria identified in Urine by Culture

4351

28818

1.44

70.19

3.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2530

15095

1.53

68.60

1.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2115

24948

0.65

67.28

3.1

3.7

10.46

10.41

mg/mmol

0.01

1285

15604

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5313

36809

1.41

64.92

4.4

5.8

1.22

1.21

mmol/l

9.17

4696

32840

(3018418) pH of Serum or Plasma

3700

24151

1.43

62.58

2.9

4.0

7.40

1.05

481

4653

(3023368) Bacteria identified in Blood by Culture

3796

25125

1.41

58.30

3.9

4.3

—

(3009508) Creatinine [Moles/volume] in Urine

2010

23422

0.66

58.24

2.6

3.1

6.92

6.56

mmol/l

3.34

1584

18838

(3012516) Albumin [Mass/volume] in Urine

2010

23415

0.66

58.12

2.7

3.2

494.81

381.44

mg/l

0.47

1241

14965

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8273

62891

1.42

52.06

19.9

19.8

32.32

28.45

mg/l

16.21

7122

53020

(3019150) Specific gravity of Urine by Refractometry

2421

15251

1.43

47.09

5.4

5.1

1.02

kg/l

0.74

368

2612

(3011397) Hemoglobin [Presence] in Urine by Test strip

2601

16637

1.41

46.30

4.4

—

(3016018) Differential panel - Cerebral spinal fluid

176

443

3.38

45.99

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

2455

26634

0.71

45.28

2.2

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2788

18196

1.39

43.62

1.8

437.83

19407939.71

pmol/l

7.72

2208

14211

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5629

40855

1.32

43.26

4.8

6.5

1.22

1.21

mmol/l

22.85

4733

33982

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1082

5853

1.61

43.16

1.9

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6511

48757

1.30

36.86

5.1

5.2

—

(40761511) CBC panel - Blood by Automated count

8116

62640

1.33

36.80

18.4

19.5

—

(3010813) Leukocytes [#/volume] in Blood

8529

66449

1.34

35.13

27.9

29.3

7.22

7.11

e9/l

1.67

8088

63684

(1761868) Lipid panel - Serum or Plasma

1174

13991

0.67

34.89

3.0

3.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

8524

66433

1.34

34.78

27.9

29.3

37.87

38.29

6.16

7474

60361

(3015736) pH of Urine

3883

27318

1.30

34.76

4.3

4.2

6.07

5.89

0.98

604

(3019550) Sodium [Moles/volume] in Serum or Plasma

8484

66080

1.34

34.73

24.0

24.2

139.66

139.38

mmol/l

13.24

8145

64093

(3035941) MCH [Entitic mass]

8524

66439

1.34

34.71

27.8

29.1

30.39

30.41

0.36

8205

64807

(3023103) Potassium [Moles/volume] in Serum or Plasma

8489

66129

1.34

34.67

24.1

24.4

4.00

4.02

mmol/l

7.23

8136

64038

(3026361) Erythrocytes [#/volume] in Blood

8524

66442

1.34

34.67

27.9

29.3

4.22

4.28

e12/l

22.63

8071

63656

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7473

57191

1.30

34.67

5.0

2.03

2.12

mu/l

4.22

6614

50167

(3007461) Platelets [#/volume] in Blood

8523

66434

1.34

34.66

27.9

29.3

235.35

235.88

e9/l

0.29

8107

63996

(3024731) MCV [Entitic volume]

8524

66443

1.34

34.66

27.8

29.2

92.01

92.04

0.25

8206

64814

(3000963) Hemoglobin [Mass/volume] in Blood

8524

66451

1.34

34.56

28.1

29.5

127.21

129.23

g/l

29.90

8195

64841

(3002179) Metamyelocytes/100 leukocytes in Blood

352

5576

0.52

32.66

2.9

3.5

0.62

0.68

0.18

111

1985

(3017181) Myelocytes/100 leukocytes in Blood

412

6211

0.54

32.46

3.0

3.6

0.98

0.92

0.14

147

2347

(3021440) Promyelocytes/100 leukocytes in Blood

384

5907

0.53

32.38

3.1

3.6

0.13

0.09

0.43

122

2056

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

624

8376

0.60

31.80

1.2

15.84

17.28

u/ml

0.13

148

2672

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

951

5347

1.54

31.72

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1363

15417

0.71

29.76

1.5

1.6

1.19

1.26

mmol/l

3.97

1215

12454

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3449

24339

1.28

28.67

2.2

2.1

261.98

223.79

u/l

1.44

3169

22511

(3025159) Blasts/100 leukocytes in Blood

364

5483

0.54

28.48

3.1

3.6

0.13

0.38

1.26

103

1669

(3035350) Ketones [Presence] in Urine by Test strip

4633

33910

1.26

28.21

4.6

0.00

estimate

0.35

685

7103

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6174

46717

1.25

27.90

3.7

4.0

15.21

15.30

pmol/l

1.90

5337

40664

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3269

23007

1.28

27.50

2.3

2.4

2.97

3.23

mg/l

6.85

2655

19294

(4035726) Immunohistochemistry procedure

466

6419

0.59

26.13

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

4576

33740

1.24

25.02

6.0

6.1

0.00

estimate

0.50

580

6395

(3026493) Urate [Moles/volume] in Serum or Plasma

1800

19010

0.76

24.29

2.3

3.0

8056.04

7239.23

umol/l

0.24

1421

15749

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

438

2173

1.72

24.11

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

556

2939

1.62

24.05

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5815

44098

1.23

23.95

4.4

4.7

7.01

6.94

mmol/l

1.19

5460

41485

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

437

2173

1.72

23.86

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

4619

34221

1.23

23.70

4.6

0.00

estimate

0.50

585

6354

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

739

8922

0.67

22.61

1.2

1.3

41.41

43.73

iu/ml

0.13

213

2750

(3037522) Nuclear Ab [Titer] in Serum

537

6919

0.64

22.55

1.2

1.3

424.78

516.13

titre

0.91

113

1655

(3013512) EKG study

2370

23978

0.79

22.51

4.4

4.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1952

13151

1.30

22.34

3.2

3.3

2.75

2.84

e6/l

0.15

1053

7561

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6080

55683

0.82

22.22

3.5

4.3

1.19

1.23

mmol/l

4.96

5086

48031

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4377

32406

1.22

22.07

4.6

4.7

53.94

96.85

ng/l

1.95

3423

26376

(3018095) Leukocytes [#/volume] in Urine

3796

27703

1.23

21.96

4.2

4.1

180.77

144.65

e6/l

0.68

2652

20562

(3019832) Treponema pallidum Ab [Presence] in Serum

239

1021

1.99

21.18

1.1

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6321

57527

0.82

20.88

3.9

4.8

1.47

1.44

mmol/l

3.10

5409

50266

(40761535) Cells panel - Urine sediment

1103

6898

1.38

20.77

3.9

3.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8188

64814

1.24

20.26

22.3

23.7

85.45

88.33

umol/l

11.12

8183

64768

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

364

4963

0.60

19.45

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2374

16734

1.25

18.27

4.3

4.4

227.02

427.08

ng/l

2.41

2164

15024

(36304419) Bacteria [Presence] in Urine

2967

21461

1.22

17.82

3.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2016

13997

1.26

17.65

2.9

3.1

1.60

1.49

e6/l

0.18

1105

8335

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6457

58257

0.84

17.39

3.9

4.8

4.33

4.29

mmol/l

1.71

5540

51407

(3029937) Albumin [Presence] in Urine by Test strip

2620

18768

1.23

17.19

5.2

4.9

0.00

estimate

0.80

541

6014

(3028026) IgM [Mass/volume] in Serum or Plasma

240

3508

0.57

16.79

2.0

1.9

2.19

1.46

g/l

1.06

189

3075

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

544

3127

1.49

16.21

1.4

1.65

1.67

0.30

439

2436

(3002582) Erythrocytes [#/volume] in Urine

3344

24753

1.19

15.25

3.6

101.96

122.36

e6/l

0.42

2527

19426

(4200892) Spirometry reversibility

376

4792

0.65

14.89

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

306

1589

1.64

14.32

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

824

9082

0.74

14.28

4.3

5.0

34.81

34.48

0.33

469

5753

(3005719) IgG [Mass/volume] in Serum or Plasma

336

4331

0.64

14.03

2.8

2.6

10.74

10.80

g/l

0.06

283

3884

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

126

502

2.12

13.64

2.5

2.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

194

2827

0.57

13.46

2.6

4.0

181.07

83.19

u/ml

1.12

182

2689

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

470

5605

0.69

13.23

2.8

2.9

54.35

55.07

ml/min/173m2

0.25

191

2681

(3002256) Pathology report gross observation

857

9294

0.76

13.19

1.4

—

(3022145) Colonoscopy Study observation

615

6989

0.72

13.00

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

959

6325

1.30

12.44

2.2

2.3

32.67

37.05

u/l

1.87

785

5326

(3003694) ABO and Rh group [Type] in Blood

1455

14619

0.81

11.69

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3486

32413

0.86

11.42

2.4

2.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

751

8124

0.76

11.29

3.7

5.7

11.47

12.41

mmol/l

2.76

681

7541

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

406

4821

0.70

11.16

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3390

25647

1.16

11.00

5.2

5.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1265

8779

1.24

10.72

2.5

2.6

5.82

5.96

ug/l

0.10

916

7272

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

902

9461

0.78

10.61

2.7

3.6

21.10

23.51

ug/l

0.11

724

7957

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6729

53513

1.15

10.49

5.5

7.4

81.43

83.67

u/l

2.21

6109

49738

(3030467) Casts [#/volume] in Urine by Automated count

3018

22703

1.16

10.45

3.5

0.62

0.53

e6/l

0.97

2280

17850

(40768797) Stomach Pathology biopsy report

894

9353

0.79

10.28

1.2

—

(3021589) Normoblasts [#/volume] in Blood

3062

28535

0.87

9.96

8.7

11.0

0.00

e9/l

1.55

2359

23087

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

115

1778

0.54

9.95

1.8

2.7

95.95

836.70

u/ml

3.48

1614

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

977

6649

1.26

9.84

1.5

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

211

2.48

9.78

3.2

2.8

27.04

29.14

umol/l

0.93

153

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

185

2501

0.62

9.64

1.5

84.44

250.78

titre

—

129

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

319

1850

1.46

9.24

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3370

31076

0.87

9.23

4.5

5.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

338

4002

0.70

9.18

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1121

11286

0.82

9.01

3.3

4.9

1.02

1.05

mmol/l

3.16

959

10180

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1058

10712

0.81

8.99

2.7

3.5

244.65

253.02

u/l

1.13

929

9945

(3014765) Yersinia sp identified in Stool by Organism specific culture

320

1875

1.45

8.80

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

320

1877

1.45

8.76

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

477

3001

1.35

8.66

1.8

2.2

1191.43

563.75

ug/l

0.77

442

2836

(3014271) Vancomycin [Susceptibility]

152

758

1.70

8.49

3.4

3.1

—

(3033658) Prothrombin time (PT) actual/Normal

2380

17827

1.16

8.44

3.4

4.0

80.14

80.51

0.28

2308

17397

(3006270) Folate [Moles/volume] in Blood

163

832

1.66

8.35

1.3

1.2

314.71

306.84

nmol/l

0.19

133

602

(4034850) Laboratory test

354

2136

1.41

8.31

12.0

14.2

—

(3042631) Mycobacterium sp identified in Specimen

1412

0.53

8.25

2.2

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

108

1606

0.56

8.23

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

271

3271

0.69

8.23

2.5

2.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

193

2478

0.65

8.04

1.2

270.13

236.31

u/ml

0.27

170

2227

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

548

0.28

7.91

1.2

1.4

—

(40768793) Breast Pathology biopsy report

1379

0.54

7.85

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

338

2045

1.40

7.83

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1332

0.53

7.79

1.2

4.25

5.20

u/ml

0.24

231

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

188

2407

0.65

7.74

1.5

1.6

37.86

38.05

u/l

0.04

141

1981

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

104

1534

0.57

7.72

1.5

1.6

13.97

12.75

mg/l

0.67

1367

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1316

0.53

7.70

1.2

4.68

6.54

u/ml

—

143

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

159

2094

0.63

7.48

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

105

1528

0.57

7.44

3.8

3.4

2.22

1.56

0.60

1297

(3000492) Spirometry study

396

4411

0.75

7.37

1.5

1.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6891

60369

0.89

7.11

4.6

5.5

2.45

2.43

mmol/l

0.78

5996

53066

(3015171) Extractable nuclear Ab [Units/volume] in Serum

147

1942

0.63

7.04

1.3

1.2

0.54

0.98

u/ml

0.59

196

(40758558) Short blood count panel - Blood

2243

16929

1.14

6.98

4.9

6.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1145

0.53

6.98

1.2

2.79

6.74

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

101

1457

0.58

6.95

1.0

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

6354

50958

1.11

6.95

24.3

23.3

15.11

15.70

14.82

6179

49816

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

431

4701

0.76

6.91

1.3

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

117

1622

0.60

6.89

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

125

1697

0.62

6.76

2.2

2.4

1.68

1.92

mg/l

2.21

101

1466

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1133

0.53

6.76

1.1

—

(3023419) Bacteria identified in Sputum by Culture

1316

0.57

6.73

1.9

2.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7971

64817

1.12

6.56

9.4

11.6

21.81

22.73

u/l

1.51

7412

61399

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

123

2.53

6.25

3.6

3.0

0.41

0.46

u/field

0.15

123

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

316

1.92

6.23

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1338

9811

1.17

6.16

10.0

9.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5173

41196

1.10

6.12

21.1

22.5

1.41

1.45

inr

1.43

1049

11416

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1042

0.54

6.09

2.7

3.4

172.38

3110.20

iu/ml

—

148

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

109

547

1.68

6.08

1.3

1.2

—

(3000012) Reticulocyte production index

123

1632

0.63

6.07

2.0

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

978

9620

0.84

6.05

1.4

1.5

2.72

2.81

g/l

0.47

408

5112

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

101

1401

0.60

6.02

1.2

45.14

44.90

u/ml

—

(40768795) Lymph node Pathology biopsy report

660

0.43

5.91

1.1

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

123

1606

0.64

5.67

1.2

1.4

1.14

g/l

0.04

107

1497

(40768443) Skin Pathology biopsy report

308

3417

0.75

5.65

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1111

0.57

5.59

1.2

1.3

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

101

1374

0.61

5.59

2.8

3.4

60.86

59.64

0.42

101

1374

(3017354) Segmented neutrophils/100 leukocytes in Blood

925

0.53

5.55

3.4

3.3

57.23

57.99

0.07

736

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

120

1567

0.64

5.55

1.2

1.4

0.24

0.23

g/l

0.11

104

1457

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1348

0.61

5.50

2.5

3.1

—

(3022096) Basophils/100 leukocytes in Blood

3399

30638

0.90

5.50

4.6

5.5

0.61

0.16

3042

27978

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

556

0.41

5.46

2.7

3.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

118

1540

0.64

5.45

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

599

6102

0.82

5.40

4.9

4.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

847

0.52

5.33

1.4

1.3

0.12

0.27

nmol/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

217

2.02

5.25

2.6

2.0

65.40

51.06

umol/l

1.89

171

(3019069) Monocytes/100 leukocytes in Blood

3522

31633

0.91

5.24

4.9

5.9

8.87

9.01

1.55

3159

28900

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

842

0.53

5.23

1.4

1.3

0.71

0.73

nmol/l

0.11

798

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1328

0.62

5.19

1.2

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

3506

31481

0.91

5.17

4.6

5.5

2.84

2.78

0.71

3145

28735

(3007566) Smooth muscle Ab [Titer] in Serum

1314

0.62

5.13

1.1

88.89

134.88

titre

—

(3001604) Monocytes [#/volume] in Blood

3704

33157

0.91

5.10

4.4

5.2

0.64

0.65

e9/l

0.53

3010

27835

(3006315) Basophils [#/volume] in Blood

3725

33314

0.91

5.01

4.4

5.2

0.04

e9/l

0.76

3023

27999

(3014111) Lactate [Moles/volume] in Serum or Plasma

1046

7649

1.17

5.00

3.7

5.2

1.55

1.40

mmol/l

3.31

1009

7368

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1074

0.59

4.96

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

772

0.52

4.96

1.4

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

418

1.70

4.92

1.1

—

3.69

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6624

57706

0.91

4.91

19.5

19.4

66.91

66.06

ml/min/173m2

2.90

5228

48170

(3000330) Specific gravity of Urine by Test strip

468

4840

0.80

4.90

4.0

4.4

—

(3004616) Nuclear Ab [Presence] in Serum

735

0.51

4.89

1.1

1.3

—

(3000494) Fungus identified in Specimen by Culture

729

7219

0.84

4.89

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

490

5039

0.81

4.87

2.5

2.6

—

(3013115) Eosinophils [#/volume] in Blood

3843

34282

0.91

4.84

4.5

5.3

0.20

e9/l

0.44

3100

29143

(4281824) Cell count and differential, peritoneal fluid

710

0.51

4.83

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

254

1.89

4.81

1.1

133.24

134.85

nmol/l

0.08

254

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

587

4100

1.22

4.74

2.5

3.6

24.00

24.11

mmol/l

0.31

554

3954

(1761482) Bacteria [#/volume] in Urine by Culture

275

3018

0.76

4.72

4.9

5.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1205

0.63

4.72

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

180

2.06

4.72

1.2

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

320

3434

0.78

4.63

2.7

2.8

52.15

91.50

mg/l

1.36

267

2785

(3002030) Lymphocytes/100 leukocytes in Blood

3593

32076

0.91

4.52

4.8

5.8

23.83

24.59

3.52

3232

29354

(40760888) Immunoglobulin light chains.free panel - Serum

230

2567

0.75

4.48

2.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

321

3425

0.78

4.45

2.7

2.8

63.96

55.33

mg/l

0.20

271

2777

(3011985) Renin [Units/volume] in Plasma

785

0.56

4.39

1.2

1.3

47.22

51.86

mu/l

0.11

679

(3045142) Bone marrow Pathology biopsy report

849

0.57

4.38

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

214

2400

0.74

4.32

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

672

0.52

4.32

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

672

0.52

4.32

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

672

0.52

4.32

1.2

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

3526

31454

0.92

4.31

4.7

5.5

60.63

59.90

2.85

3181

28782

(40765096) Chromosome analysis panel by Banding

219

0.27

4.30

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

409

4226

0.81

4.29

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

404

0.39

4.24

1.2

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

819

0.57

4.23

1.9

2.0

78.49

1053.44

u/ml

1.53

803

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

202

0.25

4.21

1.0

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3530

27979

1.09

4.12

2.6

3.0

137.42

158.85

ug/l

5.64

3070

24780

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

759

0.56

4.12

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.81

4.07

1.1

2.00

0.92

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3427

30550

0.92

4.07

2.9

3.4

2349.86

2205.73

ng/l

0.73

2872

26742

(3022313) Gas panel - Capillary blood

392

4043

0.81

4.06

3.0

3.9

—

(3052592) Norovirus Ag [Presence] in Stool

215

1.88

4.05

1.4

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

3819

33884

0.92

4.04

4.6

5.3

1.74

1.86

e9/l

1.81

3122

29095

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

743

7224

0.86

4.02

3.1

3.8

1.23

mmol/l

0.82

584

6230

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

161

1861

0.72

4.00

1.2

1.4

—

(40768800) Prostate Pathology biopsy report

141

1664

0.71

3.98

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

150

1752

0.72

3.97

1.2

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

316

3327

0.79

3.96

2.7

2.8

4.23

2.75

ratio

0.54

232

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

575

0.51

3.95

1.3

1.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.37

3.92

1.1

1.2

40.88

43.74

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

2.09

3.85

1.6

1.5

—

(3009343) pH of Capillary blood

579

5723

0.84

3.85

2.8

3.8

7.43

7.42

1.86

758

(3013707) Erythrocyte sedimentation rate by Westergren method

6065

49224

1.08

3.84

3.7

4.4

16.32

16.43

mm/h

0.18

5329

44360

(3000093) Morphology [Interpretation] in Blood Narrative

911

0.62

3.84

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1115

0.65

3.82

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1115

0.65

3.82

1.1

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

982

0.63

3.81

1.5

73.64

64.36

1.79

619

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

114

1385

0.69

3.81

1.3

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1172

10997

0.88

3.80

1.8

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

310

0.35

3.78

1.0

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

310

0.35

3.78

1.0

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

819

0.60

3.70

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

225

2447

0.77

3.70

1.9

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

402

0.44

3.68

1.1

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4404

38753

0.93

3.68

5.9

8.0

4.72

4.50

e9/l

5.12

3648

33147

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

504

0.50

3.66

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

401

4077

0.82

3.64

1.3

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

130

1527

0.71

3.60

1.8

1.9

89.22

86.98

0.58

118

1461

(3033705) Calcium.ionized [Moles/volume] in Venous blood

137

1595

0.72

3.60

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

590

5788

0.85

3.60

2.8

3.8

5.17

5.16

kpa

0.04

525

5397

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

792

0.60

3.60

1.2

—

18.10

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

145

1671

0.73

3.58

1.9

2.0

3.78

3.64

g/l

0.49

130

1571

(40768441) Liver Pathology biopsy report

373

0.43

3.56

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

672

0.57

3.53

1.0

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

808

0.61

3.52

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

961

0.65

3.49

4.5

3.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1000

0.65

3.47

1.1

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

2274

17797

1.09

3.47

2.7

2.8

5.52

5.01

e6/l

1.13

2018

15894

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

731

0.60

3.45

1.1

1.2

220.80

259.77

pmol/l

0.97

599

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

741

0.60

3.45

1.3

—

nmol/l

—

(1616796) Gas panel - Central venous blood

199

2177

0.76

3.45

3.1

3.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

130

779

1.41

3.42

1.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

997

0.66

3.42

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

760

0.61

3.41

1.4

1.5

16.10

27.01

2.78

476

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

996

0.66

3.41

1.1

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

579

5657

0.85

3.37

1.7

1.8

152.96

178.13

ug/g

1.08

430

4269

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

217

1.79

3.36

1.3

1.4

96.68

73.30

umol/l

0.47

129

(3044889) 12 lead EKG panel

5695

46246

1.07

3.35

4.6

4.8

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.74

3.29

1.1

1.2

19.29

16.72

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

997

0.66

3.28

1.1

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1007

0.67

3.27

1.1

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

567

5531

0.85

3.25

2.8

3.7

2.06

2.10

mmol/l

0.07

404

4047

(21494890) Protein electrophoresis panel - 24 hour Urine

995

0.67

3.25

1.8

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.28

3.24

1.1

1.2

23.25

50.48

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

118

1379

0.72

3.22

1.4

1.3

36.53

41.57

u/l

0.25

1169

(3027273) Bicarbonate [Moles/volume] in Venous blood

510

5011

0.85

3.20

2.5

3.5

25.24

25.09

mmol/l

0.47

490

4875

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1022

0.67

3.20

1.2

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

931

0.66

3.20

1.5

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

247

0.34

3.18

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

909

0.65

3.17

1.2

83.28

48.49

u/ml

—

103

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

640

0.59

3.16

1.1

154.08

489.06

iu/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

241

2542

0.79

3.14

1.1

77.88

124.16

iu/ml

1.22

805

(3020876) Protein [Mass/time] in 24 hour Urine

1007

0.67

3.13

2.1

2.2

0.91

1.03

g/24h

0.14

472

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

125

1439

0.73

3.12

2.4

2.1

206.58

215.78

0.56

111

1348

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

305

0.41

3.11

1.0

294.50

296.91

mg/l

—

261

(3011412) CD3 cells [#/volume] in Blood

475

0.53

3.10

2.6

1.7

1.21

1.03

e9/l

0.59

434

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

314

0.43

3.05

1.1

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

218

1.74

3.04

1.1

45.92

46.24

mg/l

0.02

183

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

282

1.64

3.03

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

196

2102

0.78

2.96

1.9

2.2

84.85

99.77

ug/min

0.24

100

1165

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

297

1.62

2.96

1.1

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

148

931

1.34

2.95

3.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

388

0.50

2.92

1.0

1.1

46.11

30.56

u/l

0.33

330

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

476

0.55

2.91

2.0

2.2

26.80

97.64

ug/min

—

114

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

881

0.67

2.91

1.2

1.1

—

(3008898) HLA-B27 [Presence]

759

0.64

2.90

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

540

0.57

2.90

1.2

1.3

14.92

14.04

u/l

0.12

414

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

624

0.60

2.89

1.0

1.1

263.93

301.47

u/ml

0.37

356

(3004775) Volume in Urine collected for unspecified duration

746

0.64

2.86

2.1

668.17

652.32

0.10

458

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

205

2174

0.79

2.84

1.4

—

(3021901) Oxygen saturation in Capillary blood

183

1967

0.78

2.83

2.4

2.9

—

(3006462) Nitrate [Presence] in Urine

405

0.52

2.81

3.2

4.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

215

1435

1.27

2.79

1.5

1.9

25.04

31.85

umol/l

7.54

169

1222

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.37

2.79

2.3

2.5

137.15

133.51

nmol/l

0.06

(3035637) Corticotropin [Mass/volume] in Plasma

669

0.63

2.78

1.0

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

254

0.40

2.77

1.9

2.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

300

3046

0.82

2.77

2.4

2.8

355.36

2962.45

u/ml

1.97

236

2585

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1366

12490

0.91

2.77

2.1

2.6

19.70

20.51

1.40

1032

10416

(3024980) IgG subclass 4 [Mass/volume] in Serum

755

0.66

2.69

1.4

1.5

0.57

0.83

g/l

1.42

562

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

702

0.65

2.66

1.2

1.4

—

(3051651) Icteric interference index of Serum or Plasma

484

1.45

2.63

3.4

—

(21494434) Karyotype in Bone marrow

760

0.66

2.61

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

281

1.59

2.60

1.2

0.68

0.96

promille

0.82

202

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1064

0.72

2.57

1.2

1.3

0.75

0.78

nmol/l

0.24

848

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

614

0.63

2.56

1.2

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

108

1228

0.74

2.56

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

765

0.67

2.54

2.0

1.9

—

0.51

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

684

0.65

2.54

1.2

121.94

120.60

u/ml

0.04

158

(3004451) EKG impression Narrative

529

0.60

2.53

1.1

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

663

0.65

2.53

1.2

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

163

1748

0.78

2.52

1.4

1.5

30.03

30.61

g/l

0.27

141

1544

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1447

13136

0.92

2.51

2.0

2.5

2.17

2.23

g/l

4.42

1250

11904

(3024354) Oxygen [Partial pressure] in Venous blood

964

7352

1.11

2.51

2.3

3.1

4.11

4.32

kpa

2.73

905

7066

(40767503) Oxygen content in Capillary blood by calculation

194

2031

0.80

2.45

2.4

2.6

16.32

15.48

1.94

1089

(3028717) Thiamine [Mass/volume] in Blood

2.51

2.45

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

126

1.87

2.45

1.1

1.3

89.88

105.55

ug/l

0.27

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1053

0.72

2.43

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

777

0.68

2.42

1.1

1.2

53.22

60.25

u/l

0.62

692

(3037692) Legionella sp identified in Specimen by Organism specific culture

237

0.43

2.39

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

1592

0.78

2.37

1.4

1.5

32.86

5.63

iu/ml

0.70

437

(3017446) Testosterone [Moles/volume] in Serum or Plasma

325

3219

0.84

2.34

1.9

9.64

9.95

nmol/l

0.25

264

2645

(3040151) Glucose [Moles/volume] in Capillary blood

172

1146

1.27

2.33

6.3

9.5

7.46

7.38

mmol/l

0.11

134

928

(3027315) Oxygen [Partial pressure] in Blood

205

2119

0.81

2.32

3.7

4.5

7.83

8.22

kpa

3.30

194

2048

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

100

1131

0.74

2.32

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

186

0.41

2.32

3.3

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

141

1.79

2.31

1.2

1.3

—

(3045424) Erythrocytes [Presence] in Urine

1101

0.74

2.31

1.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

101

626

1.36

2.30

1.1

34.22

34.86

mmol/l

0.10

520

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

494

0.61

2.29

1.4

54.83

68.66

1.30

393

(3010375) cycloSPORINE [Mass/volume] in Blood

159

0.37

2.29

25.0

22.8

78.71

100.14

ug/l

—

131

(3044640) Blood type and Crossmatch panel - Blood

2698

23833

0.94

2.28

2.3

2.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

2.27

0.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

736

6871

0.89

2.26

2.2

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

654

0.67

2.24

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

319

0.53

2.21

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

162

1.72

2.21

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

771

5855

1.12

2.20

4.3

6.2

24.49

24.53

mmol/l

0.12

740

5559

(3020630) Protein [Mass/volume] in Serum or Plasma

884

8156

0.90

2.19

2.1

2.4

65.46

65.61

g/l

0.22

725

7158

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

284

0.50

2.18

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4228

34327

1.06

2.17

2.8

3.1

50.07

57.81

u/l

5.29

3673

30420

(3013290) Carbon dioxide [Partial pressure] in Blood

206

2111

0.82

2.17

3.7

4.5

5.05

5.02

kpa

0.17

196

2040

(3012501) Base excess in Blood by calculation

206

2109

0.82

2.15

3.7

4.5

2.85

mmol/l

0.01

141

1449

(3034891) Synovial lining cells/100 cells in Synovial fluid

369

0.57

2.13

1.2

1.4

2.50

3.33

—

(3024928) Oxygen saturation in Venous blood

243

1700

1.21

2.13

1.7

2.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1482

11641

1.08

2.07

2.1

2.2

1.73

1.76

0.71

1181

10030

(3014891) Appearance of Pleural fluid

211

1.60

2.07

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

256

2551

0.84

2.02

2.4

3.2

25.06

25.02

mmol/l

0.05

248

2491

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

342

3327

0.86

2.01

3.2

4.3

25.08

24.88

mmol/l

0.53

285

2966

(3017732) Neutrophils [#/volume] in Blood

441

4209

0.88

1.98

3.3

3.4

5.81

5.85

e9/l

0.01

294

2933

(3008295) Osmolality of Serum or Plasma

118

768

1.30

1.97

1.3

274.63

274.28

mosm/kgh2o

0.05

544

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

104

666

1.32

1.96

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

260

1848

1.19

1.95

4.2

4.0

31.60

30.97

mg/l

0.09

191

1258

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1425

12803

0.93

1.95

2.0

2.6

0.82

0.81

mmol/l

0.09

1215

11639

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1191

9301

1.09

1.93

3.2

3.3

247.26

296.04

ng/l

3.17

1093

8532

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

511

0.66

1.91

1.3

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

398

0.61

1.90

5.3

4.7

120.09

144.30

u/ml

—

118

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

118

0.36

1.90

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.89

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

509

0.66

1.88

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

299

2919

0.86

1.87

2.4

2.7

0.30

0.31

g/l

0.12

1104

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

102

657

1.31

1.86

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

457

0.64

1.86

1.0

1.1

117.81

114.63

0.36

390

(21494814) CD8 cells/100 lymphocytes in Specimen

201

0.46

1.86

3.7

1.7

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

426

0.63

1.85

1.4

1.5

4.10

2.64

0.35

350

(3016750) Collection duration of Urine

507

0.66

1.85

2.2

1.9

484.24

502.13

min

0.37

348

(44813793) Dust mix specific IgE antibody measurement

267

0.53

1.84

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

256

0.52

1.84

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

310

0.57

1.84

1.8

675.19

486.53

e6/l

0.79

267

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

391

1.40

1.84

1.2

1.1

2.13

2.22

mmol/l

0.37

351

(3000034) Microalbumin [Mass/volume] in Urine

733

0.72

1.83

2.6

3.1

36.69

34.60

mg/l

0.05

550

(3006442) Creatine [Moles/volume] in Serum or Plasma

414

0.63

1.83

2.1

1.9

94.45

104.48

umol/l

0.78

414

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

1.46

1.81

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

552

0.68

1.77

1.1

1.2

1.57

4.15

u/ml

—

170

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1643

14633

0.93

1.77

1.6

1.79

1.65

mg/l

0.80

1268

11508

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

1.72

1.76

1.2

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1216

10945

0.93

1.75

1.2

1.47

1.66

u/ml

0.26

236

2525

(3017569) Oxygen content in Arterial blood

500

0.67

1.74

1.9

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

668

0.72

1.74

1.1

—

u/ml

—

(21494755) Public health laboratory ask at order entry panel

229

0.51

1.74

1.4

—

(4062490) Immunoglobulin typing, IgG

469

0.66

1.73

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.72

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.72

0.0

1.1

—

(3021788) Differential panel - Synovial fluid

137

1423

0.81

1.72

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

655

0.72

1.70

8.0

13.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1019

0.77

1.70

2.4

3.6

30.88

45.61

u/ml

1.03

988

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

109

1160

0.79

1.70

1.3

438.04

370.07

u/l

0.19

1093

(3018405) Lactate [Moles/volume] in Arterial blood

439

3285

1.13

1.69

2.6

3.7

1.42

1.44

mmol/l

0.09

432

3215

(3012565) Volume of 24 hour Urine

333

0.61

1.68

2.2

1529.44

1778.51

0.57

276

(3021879) Hepatitis B virus core Ab [Presence] in Serum

260

2536

0.86

1.64

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

104

1107

0.79

1.63

1.3

1.4

6.56

6.42

mmol/l

0.20

1035

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

330

0.61

1.63

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

330

0.61

1.63

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

329

0.61

1.61

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

329

0.61

1.61

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

329

0.61

1.61

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

329

0.61

1.61

1.0

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

622

5737

0.91

1.60

2.3

3.3

126.56

124.94

g/l

1.16

605

5598

(40768446) Kidney Pathology biopsy report

145

0.46

1.59

1.0

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

358

0.63

1.58

2.7

1.8

—

(3047189) Immunofixation for 24 hour Urine

428

0.67

1.57

1.1

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

468

0.68

1.57

1.1

1.3

2.84

g/l

0.00

330

(3024139) IgG subclass 3 [Mass/volume] in Serum

468

0.68

1.57

1.1

1.3

0.48

g/l

0.01

331

(3027135) IgG subclass 1 [Mass/volume] in Serum

468

0.68

1.57

1.1

1.3

6.23

7.14

g/l

0.95

326

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

186

0.50

1.54

1.4

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

208

0.53

1.54

1.3

1.1

108.54

141.20

mmol/24h

1.29

208

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

122

0.41

1.53

12.5

13.0

5.80

5.47

mmol/l

—

122

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1651

14627

0.94

1.52

3.0

3.5

0.88

0.89

ug/l

0.15

1205

10876

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

115

1.68

1.52

2.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

533

0.71

1.51

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

523

0.71

1.50

3.1

2.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.52

1.50

1.3

1.1

—

(4146454) Self-monitoring of blood glucose

934

0.78

1.49

2.5

2.7

—

(3025130) Human papilloma virus identified in Specimen

270

0.59

1.49

2.1

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

311

0.62

1.48

6.2

5.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

141

0.48

1.48

2.9

2.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

248

0.58

1.48

1.5

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2032

17877

0.95

1.48

2.2

2.5

—

(3003181) Sodium [Moles/volume] in Urine

244

1774

1.16

1.47

1.3

62.55

60.71

mmol/l

0.33

195

1417

(3007930) Methemoglobin/Hemoglobin.total in Blood

417

3907

0.89

1.47

3.3

4.4

0.91

0.86

2.32

393

3677

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

989

7763

1.08

1.47

2.2

2.5

10.10

10.09

umol/l

0.00

793

6695

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

129

0.46

1.44

1.0

1.3

166.70

140.52

pmol/l

—

129

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

108

1123

0.81

1.42

1.3

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

338

0.65

1.42

2.0

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

368

0.66

1.42

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

487

1.30

1.37

2.8

2.1

1.53

2.59

u/field

1.20

314

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

483

0.71

1.36

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.36

0.0

13.2

—

220.15

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

102

690

1.25

1.35

1.1

—

(40758358) Immune stain study

0.00

1.34

0.0

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

6.4

—

1.05

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

282

0.63

1.34

2.0

2.4

45.30

36.81

—

177

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

452

0.71

1.34

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

187

0.54

1.33

1.8

1.5

9.28

10.55

ug/l

0.21

166

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

425

3952

0.90

1.33

3.4

4.4

1.60

1.53

1.18

402

3724

(3008536) Aspergillus sp Ab [Presence] in Serum

125

0.47

1.33

2.0

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

484

4469

0.91

1.32

5.0

7.7

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

146

0.52

1.30

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

146

0.52

1.30

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

146

0.52

1.30

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

146

0.52

1.30

1.4

51.89

212.95

nmol/24h

—

146

(42529582) MDA5 Ab [Presence] in Serum by Line blot

146

0.52

1.30

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

527

0.73

1.30

1.1

1.2

5.68

4.54

u/ml

0.21

233

(3035880) pH of Pleural fluid

689

0.77

1.29

1.1

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

103

1062

0.81

1.28

1.6

1.7

4.20

4.27

mmol/24h

0.06

865

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

196

1.46

1.28

1.1

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

184

0.55

1.27

3.5

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

167

1645

0.85

1.27

1.2

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

928

0.80

1.24

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

116

1.60

1.23

2.3

2.2

—

(3045414) Leukocytes [Presence] in Urine

328

3076

0.89

1.22

2.2

2.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

102

700

1.23

1.21

1.3

1.4

297.65

328.40

titre

0.08

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

364

0.69

1.20

1.0

1.1

97.52

89.01

1.31

329

(3023199) Leukocytes [#/volume] in Pleural fluid

154

1515

0.85

1.17

1.4

1.5

4205.38

1855.29

e6/l

0.78

104

1102

(3038071) Oxygen [Partial pressure] in Mixed venous blood

109

0.46

1.17

4.3

8.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

828

0.80

1.17

1.3

1.4

14.15

13.78

u/l

0.22

789

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

279

1.36

1.16

2.1

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

279

1.36

1.16

2.1

2.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

458

0.73

1.15

1.5

6.35

6.47

u/l

0.01

360

(3036603) Volume of Urine

458

0.73

1.15

1.9

1.4

1495.78

1719.47

1.46

432

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

1.15

0.0

1.5

—

(3003396) Base excess in Arterial blood by calculation

1306

10448

1.06

1.14

3.9

5.6

1.10

1.20

mmol/l

0.35

985

8097

(3026782) Osmolality of Urine

2169

17580

1.05

1.13

3.0

3.3

559.24

531.73

mosm/kgh2o

8.52

1780

15040

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1008

0.82

1.12

3.2

3.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

228

0.63

1.12

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

692

0.79

1.11

1.2

—

(3018572) Chloride [Moles/volume] in Blood

249

1857

1.13

1.11

3.9

5.8

104.50

104.80

mmol/l

0.41

229

1655

(3039000) Anion gap in Blood

249

1857

1.13

1.11

3.9

5.8

11.30

11.33

mmol/l

0.06

229

1655

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

137

0.55

1.09

4.7

8.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

137

0.55

1.09

1.4

—

(3022621) pH of Urine by Test strip

659

5164

1.08

3.8

3.7

—

(3019225) pH of Specimen

978

8699

0.94

1.07

4.0

4.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

509

0.76

1.07

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

120

850

1.19

1.07

1.8

1.6

32.16

25.67

u/ml

0.83

178

(3022948) Iron [Moles/volume] in Serum or Plasma

1609

14112

0.95

1.07

2.0

2.5

10.78

11.35

umol/l

2.73

1394

12852

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

106

0.48

1.05

1.0

1.1

753.17

1818.07

miu/ml

—

106

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1600

12900

1.05

1.7

1.9

29.69

30.29

3.07

1533

12501

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2141

18646

0.96

1.05

2.5

3.0

35.02

36.70

u/l

0.56

1952

17360

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

712

0.80

1.03

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.85

1.02

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.85

1.02

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.85

1.02

1.0

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

711

0.80

1.02

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

748

0.81

1.02

1.0

—

(40768806) Pleura Pathology biopsy report

133

1305

0.86

1.02

1.4

1.6

—

(3048879) Bone marrow aspiration report

302

0.70

1.02

1.1

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

754

0.81

0.99

1.4

1.5

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.99

0.0

1.1

—

16.67

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

680

1.20

0.98

1.3

51.43

55.83

titre

—

(3032057) Clostridioides difficile [Presence] in Stool

244

1.35

0.98

1.6

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

280

0.69

0.98

1.4

1.1

0.31

0.72

u/ml

1.73

137

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

179

0.61

0.98

1.5

1.3

26.78

29.81

umol/l

0.86

171

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1036

8276

1.06

0.98

4.2

6.3

119.94

118.15

g/l

2.18

1011

8039

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

972

0.84

0.97

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

916

0.83

0.95

1.2

1.3

26.06

12.01

u/l

1.47

835

(3044927) Protein electrophoresis panel - Urine

111

1098

0.85

0.95

1.3

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

258

0.68

0.95

2.0

1.6

1143.00

1674.38

u/ml

0.73

247

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

451

0.76

0.94

1.1

1.2

99.93

96.16

u/l

0.07

391

(3010421) pH of Blood

257

2399

0.90

0.94

3.3

4.3

7.42

0.38

211

2173

(3041918) Cholesterol [Moles/volume] in Pleural fluid

207

0.65

0.93

1.1

1.2

1.68

1.41

mmol/l

—

121

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

548

4939

0.93

0.92

1.5

1.6

1.61

1.55

g/l

0.73

425

4188

(3011288) Drugs identified in Urine by Screen method

1.78

0.92

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

266

0.69

0.92

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.68

0.91

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

438

0.77

0.90

3.6

3.1

—

(3028433) Virus identified in Specimen by Culture

215

0.66

0.90

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

144

1386

0.87

0.88

1.4

28781.96

64222.05

e6/l

2.81

827

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

143

0.59

0.88

4.0

2.3

—

(3014051) Protein [Presence] in Urine by Test strip

216

2026

0.89

0.88

2.6

3.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.02

0.87

1.5

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

243

0.69

0.87

2.6

2.0

—

(3012441) Differential panel - Pleural fluid

135

1303

0.87

1.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

213

0.67

0.86

1.5

7.60

7.38

—

104

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

452

0.78

0.84

1.1

1.2

88.57

122.56

titre

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

536

0.80

0.84

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

117

0.57

0.84

1.0

1.3

1.54

1.53

g/l

—

117

(3008401) Mugwort IgE Ab [Units/volume] in Serum

230

0.69

0.82

1.1

1.0

0.03

1.33

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

317

0.74

0.81

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

259

0.71

0.81

1.2

1.9

725.64

6073.96

e6/l

0.89

181

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.66

0.81

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

278

0.73

0.81

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

606

0.82

0.80

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.80

0.0

2.1

—

(3020650) Glucose [Presence] in Urine

125

0.61

0.79

2.9

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.79

0.0

2.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.50

0.78

1.4

1.5

48.40

51.93

pmol/l

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1291

10447

1.04

0.77

3.9

5.6

4.90

5.05

kpa

6.21

1218

9816

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

187

0.67

0.76

1.3

1.5

0.50

0.40

ug/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

388

3033

1.08

0.75

3.7

3.3

0.77

0.82

nmol/l

1.65

302

2350

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

136

1008

1.14

0.75

1.8

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

514

4598

0.94

0.74

3.0

4.3

45.59

45.96

0.14

504

4547

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

399

3125

1.08

0.74

2.4

3.0

4.30

4.23

pmol/l

0.66

325

2644

(3027801) Oxygen [Partial pressure] in Arterial blood

1289

10442

1.04

0.74

3.9

5.6

11.54

11.58

kpa

0.09

1217

9804

(3051101) Glucose [Moles/volume] in Cord blood

205

0.70

0.73

5.9

5.6

—

(3034426) Prothrombin time (PT)

115

0.58

0.73

1.1

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

234

0.72

0.73

1.1

1.0

1.57

1.23

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.56

0.73

2.5

1.3

53.42

42.39

mg/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

525

4688

0.94

0.72

4.9

6.8

24.09

24.40

mmol/l

1.15

481

4417

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.68

0.72

1.7

1.2

1.60

1.07

u/field

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

478

0.81

0.72

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

478

0.81

0.72

1.4

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

144

0.64

0.71

1.1

1.2

36.40

299.82

u/l

—

(3052851) Hemolysis interference index of Serum or Plasma

340

2652

1.08

0.71

3.3

3.6

—

(3002619) Bacteria identified in Specimen by Culture

164

0.67

0.71

1.5

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

164

0.67

0.71

1.2

1.1

3.04

4.04

u/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

465

0.81

0.68

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

436

0.81

0.66

1.1

1.2

38.66

30.88

u/l

0.30

369

(3026470) Cobalt [Mass/volume] in Blood

610

0.84

0.66

1.9

1.8

3.41

4.15

ug/l

0.34

551

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

151

0.67

0.66

1.0

1.1

—

1.76

—

(3045788) Cell count panel - Pleural fluid

122

1157

0.89

0.66

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

206

1895

0.91

0.64

1.6

27590.30

14916.79

e6/l

1.30

145

1353

(3026389) Candida sp identified in Specimen by Organism specific culture

931

0.88

0.63

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

331

0.79

0.63

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

284

0.77

0.63

1.2

40.66

40.04

g/l

0.12

135

(3023383) Lactate [Moles/volume] in Pleural fluid

377

0.80

0.63

1.3

4.07

3.36

mmol/l

0.54

343

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.59

0.62

4.3

7.4

—

(3049717) Cytology report of Urine Cyto stain

455

4056

0.94

0.62

2.7

2.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

236

0.75

0.62

1.2

1.7

3052.00

20255.16

e6/l

—

139

(3010144) Erythrocytes [#/volume] in Synovial fluid

759

0.86

0.62

1.3

214104.10

196405.34

e6/l

0.06

520

(3023520) Reticulocytes [#/volume] in Blood

1003

8759

0.96

0.62

2.2

2.4

64.81

66.88

e9/l

1.11

722

6704

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6898

58545

0.98

0.61

6.2

7.1

41.78

41.60

mmol/mol

0.69

6024

52051

(3044242) Glucose [Moles/volume] in Arterial blood

480

1.17

0.61

1.5

1.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.61

0.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

253

0.76

0.59

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

253

0.76

0.59

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

113

1067

0.89

0.59

4.8

5.8

13.11

12.81

mg/l

0.26

951

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

3891

0.94

0.59

2.0

2.2

3.85

3.68

g/l

1.07

347

3388

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.61

0.58

1.0

1.3

2.33

1.81

umol/l

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.58

0.0

1.2

—

17.94

—

(3020891) Body temperature

455

3622

1.06

0.57

3.2

4.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1057

8587

1.04

0.56

4.3

4.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.55

0.56

1.4

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.48

0.56

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

223

1.25

0.55

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

0.65

0.55

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

106

0.63

0.55

1.0

1.2

—

13.53

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2001

17220

0.97

0.54

4.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

515

0.85

0.54

1.0

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

360

0.82

0.54

1.3

740.27

275.91

ug/l

0.31

193

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

149

1.30

0.53

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

210

1906

0.93

0.51

1.8

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

448

0.84

0.50

1.6

2.1

19.57

25.26

umol/l

0.42

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

199

0.76

0.50

1.1

—

(3016502) Oxygen saturation in Arterial blood

1140

9300

1.03

0.50

4.1

5.8

94.85

95.07

0.40

1094

8890

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

403

3214

1.06

0.50

2.2

2.5

36.89

24.25

au/ml

—

125

(40762814) Titanium [Mass/volume] in Blood

170

0.74

0.49

2.3

1.9

2.86

3.29

ug/l

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

441

3899

0.95

0.49

2.0

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

319

1.19

0.49

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

3675

0.95

0.49

1.9

2.2

10.54

10.38

g/l

0.22

322

3131

(3003327) Ova and parasites identified in Stool by Light microscopy

162

1482

0.92

0.49

1.5

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

246

2213

0.93

0.49

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.63

0.48

1.0

1.1

—

(1002224) Polysomnography panel

101

762

1.12

0.48

1.0

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

442

3904

0.95

0.48

2.0

2.2

7.70

7.56

g/l

0.87

349

3396

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

409

0.84

0.48

1.5

1.6

178.34

185.61

pmol/l

0.24

360

(3038177) Helicobacter pylori Ab [Presence] in Serum

651

0.88

0.47

1.6

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

159

0.74

0.47

1.1

0.47

0.67

umol/24h

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

103

961

0.90

0.47

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

206

0.78

0.47

1.2

—

0.47

g/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

120

0.70

0.46

1.0

1.2

—

(3047181) Lactate [Moles/volume] in Blood

332

2642

1.06

0.45

3.7

5.2

1.42

1.37

mmol/l

0.37

300

2342

(3028679) Herpes simplex virus Ab [Presence] in Serum

167

0.76

0.45

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

195

0.78

0.45

1.7

2.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

375

2998

1.05

0.44

1.9

2.1

36.26

36.63

g/l

0.51

278

2479

(3020961) Endomysium IgA Ab [Titer] in Serum

221

1986

0.93

0.44

1.1

645.00

225.38

titre

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

222

0.80

0.43

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.45

0.43

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

494

0.87

0.43

1.8

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

165

0.76

0.42

1.3

1.4

135.51

126.01

ng/l

0.11

165

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

127

0.73

0.42

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

118

907

1.10

0.42

2.6

2.4

2.53

2.20

u/field

0.27

283

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.41

0.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

438

0.86

0.41

1.4

1.2

—

(3036180) Methadone [Presence] in Urine

1.50

0.41

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.40

0.0

7.2

—

45.27

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.40

0.0

7.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

686

0.89

0.40

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

374

1.15

0.40

1.1

1.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.39

0.0

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.39

0.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

454

0.87

0.39

1.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

454

0.87

0.39

1.0

1.4

—

(3022689) Creatine [Moles/volume] in Urine

163

0.77

0.39

1.3

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.32

0.38

4.4

5.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

520

4541

0.96

0.38

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

143

0.76

0.37

1.5

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

124

0.75

0.37

1.4

1.6

8.02

9.71

ug/l

1.22

124

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

414

3629

0.96

0.37

2.0

2.5

0.36

0.35

u/ml

0.36

224

2082

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

848

6935

1.03

0.36

2.7

3.5

88.23

100.17

ng/l

3.92

682

5679

(3002032) Base excess in Venous blood by calculation

1082

8882

1.03

0.36

2.5

3.6

2.01

1.95

mmol/l

0.19

886

7389

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.63

0.35

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.36

0.34

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.67

0.33

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.29

0.33

1.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1082

8900

1.02

0.32

2.5

3.6

5.83

kpa

0.05

1023

8594

(3011648) Oxygen content in Venous blood

507

0.90

0.32

1.2

1.5

10.12

10.03

0.05

507

(3042010) Triglyceride [Moles/volume] in Pleural fluid

148

0.80

0.31

1.1

1.2

0.95

1.94

mmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.34

0.31

1.1

1.3

—

(3044941) Cell count panel - Synovial fluid

154

1218

1.06

0.30

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

282

0.86

0.29

1.3

1.4

14.19

21.72

0.90

228

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

548

4747

0.97

0.29

4.0

5.8

24.76

24.86

mmol/l

0.23

540

4677

(3025577) Chromium [Mass/volume] in Blood

591

0.91

0.29

2.0

1.9

1.98

2.21

ug/l

0.30

492

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

155

0.81

0.28

1.3

1.1

256.22

265.55

pmol/l

—

100

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

155

0.81

0.28

1.2

1.3

81.79

74.78

—

133

(3007853) Bacteria identified in Skin by Aerobe culture

1068

8802

1.02

0.28

1.7

1.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

281

0.87

0.28

1.4

1.5

5.00

6.38

u/l

1.17

227

(3024263) Appearance of Synovial fluid

418

1.11

0.28

1.2

1.3

—

(36660697) Celiac disease serology panel - Serum

469

3823

1.03

0.27

1.2

—

(3015183) Erythrocyte sedimentation rate

101

0.75

0.27

1.0

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.70

0.26

7.6

4.4

30.60

62.26

ug/min

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

482

0.91

0.26

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.68

0.26

1.0

1.1

—

0.46

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

216

0.86

0.25

2.0

2.6

7.08

7.48

mmol/l

0.48

146

(3019060) Gas panel - Arterial blood

773

6358

1.02

0.25

3.1

4.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.22

0.25

12.4

12.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

229

1.14

0.25

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.18

0.24

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

295

0.88

0.24

1.1

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

179

0.85

0.24

1.3

30.02

21.70

—

137

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

321

2608

1.04

0.24

2.0

2.2

0.00

g/l

0.22

263

2329

(3025549) Creatine [Moles/time] in 24 hour Urine

0.72

0.24

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

106

0.79

0.24

1.1

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

151

1.17

0.23

1.0

1.2

125.64

144.72

nmol/l

0.25

111

(3037756) Immunofixation for Serum or Plasma

253

2208

0.96

0.23

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.27

0.23

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

293

0.89

0.22

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

388

3360

0.97

0.22

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.75

0.22

1.0

1.1

—

0.52

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

663

5457

1.02

0.22

1.7

2.0

411.72

386.46

nmol/l

2.33

555

4883

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

0.82

0.22

1.4

1.2

—

(3033799) Differential panel - Peritoneal fluid

239

0.88

0.22

1.3

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.20

0.21

1.2

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

54.73

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.21

1.8

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.20

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

9.1

—

55.60

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

3.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.17

0.21

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

8.42

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

314

2561

1.03

0.20

2.0

2.3

0.00

g/l

-0.00

262

2319

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

478

4118

0.98

0.20

1.7

1.8

3.33

2.36

ug/l

0.44

359

3501

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.20

0.0

7.8

—

28.93

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.20

0.0

17.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

413

3564

0.97

0.20

2.0

2.3

3.07

3.03

g/l

0.22

320

3057

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.23

0.20

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

351

0.91

0.19

1.0

2.5

58.09

67.49

mg/l

0.57

224

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

340

2781

1.03

0.19

2.0

2.2

0.02

0.06

g/l

1.89

280

2488

(4212803) Bone marrow aspirate examination

1.19

0.19

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

341

0.91

0.18

1.0

1.1

0.23

11.47

nmol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.24

0.18

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3159

26377

1.01

0.18

4.8

5.8

8.00

5.28

ug/l

0.65

2695

22880

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

120

0.84

0.18

1.1

1.2

15.67

17.48

u/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

394

3235

1.03

0.18

2.0

2.4

1.47

1.23

g/l

0.37

300

2659

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

173

0.87

0.17

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.17

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

116

1.16

0.17

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.75

0.17

1.0

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

332

2863

0.97

0.17

1.2

1.3

53.47

60.54

au/ml

0.19

153

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

137

0.86

0.17

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

172

0.88

0.16

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

251

0.90

0.16

1.4

1.2

5.91

14.16

umol/l

1.87

168

(3020491) Glucose [Moles/volume] in Blood

520

0.94

0.16

1.9

2.5

6.83

7.35

mmol/l

1.02

354

(3005011) Chlamydia sp Ab [Titer] in Serum

1.12

0.16

2.3

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.78

0.15

1.3

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.16

0.15

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

206

0.90

0.15

1.2

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.11

0.15

1.8

1.5

—

(3017704) Immunofixation for Urine

544

0.94

0.15

1.5

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

162

0.88

0.15

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

100

0.84

0.15

1.4

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

310

0.92

0.14

5.6

5.1

64.92

72.90

0.68

240

(3019977) pH of Arterial blood

586

0.95

0.14

2.0

2.4

7.42

0.04

236

(3000991) Gas panel - Venous blood

859

7315

0.99

0.14

4.2

6.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.80

0.13

1.9

1.7

1.64

0.69

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

0.91

0.13

1.0

1.1

6.62

12.39

iu/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

143

1.12

0.13

1.1

—

(3001729) Color of Synovial fluid

0.81

0.13

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

442

3658

1.02

0.12

1.9

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4589

38453

1.01

0.11

3.9

5.7

12.75

12.65

umol/l

0.17

4174

36277

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

862

0.97

0.11

2.4

2.9

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

262

0.93

0.10

1.4

71.06

62.53

0.80

225

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

390

0.95

0.10

1.5

1.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.14

0.10

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.11

0.10

1.2

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

526

0.96

0.09

1.0

1.1

—

23.70

—

(3003740) Influenza virus B Ag [Presence] in Specimen

200

0.92

0.09

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

173

0.92

0.08

1.3

1.1

1.06

1.14

u/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.80

0.07

1.3

1.2

8.50

12.71

u/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.09

0.07

1.0

1.1

1.50

1.67

umol/24h

—

(3036489) Thrombin time

256

2185

0.98

0.07

1.7

20.93

22.19

1.86

235

1994

(3018851) Theophylline [Moles/volume] in Serum or Plasma

107

1.10

0.07

1.6

44.43

47.48

umol/l

0.16

107

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

172

0.93

0.07

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.84

0.07

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2490

21018

1.00

0.07

4.5

5.1

21.98

22.65

1.38

1250

11794

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

651

5430

1.01

0.07

4.5

6.9

0.73

0.67

2.60

645

5381

(3027944) Amphetamines [Presence] in Urine

0.87

0.07

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

190

1.06

0.06

1.3

1.4

17.77

16.65

pmol/l

0.45

144

(3023323) Follitropin [Units/volume] in Serum or Plasma

214

0.94

0.06

1.1

1.4

65.22

35.87

iu/l

2.15

180

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

149

1.07

0.06

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

290

1.04

0.06

2.2

2.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

119

0.92

0.05

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

382

1.03

0.05

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

306

0.96

0.05

2.9

6.3

24.92

24.54

mmol/l

0.28

277

(3027923) C peptide [Moles/volume] in Serum or Plasma

323

0.96

0.05

1.1

1.2

1.32

1.15

nmol/l

0.44

241

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.11

0.05

15.3

12.3

13.92

14.13

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

558

4723

0.99

0.05

3.2

3.0

0.40

0.33

e6/l

0.63

546

4641

(3002523) Influenza virus A Ag [Presence] in Specimen

195

0.95

0.04

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

256

2174

0.99

0.04

2.1

2.3

127.00

124.18

g/l

0.99

192

1609

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

151

1.06

0.04

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7184

60468

1.00

0.04

4.7

5.5

6.15

mmol/l

0.04

6176

52550

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

100

0.93

0.03

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

294

1.03

0.03

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.92

0.03

1.4

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

169

1.05

0.03

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2721

22917

1.00

0.03

2.2

2.5

58.78

64.17

u/l

0.83

2452

20920

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

473

3961

1.00

0.02

1.9

2.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

186

1552

1.01

0.02

1.6

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

588

1.02

0.02

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

255

2133

1.01

0.02

1.3

1.4

260.30

259.42

ug/g

0.02

128

1329

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

825

6948

1.00

0.01

1.6

1.9

0.20

0.19

g/l

1.24

708

6320

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

126

1066

0.99

0.01

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

123

0.96

0.01

1.1

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

502

0.99

0.01

1.2

1.04

1.47

nmol/l

4.02

446

(3000764) Benzodiazepines [Presence] in Urine

1.06

0.01

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

224

0.98

0.00

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

426

0.99

0.00

1.5

1.7

—

(3027008) Opiates [Presence] in Urine

1.05

0.00

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.05

0.00

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

167

1.01

0.00

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

1.02

0.00

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

106

1.03

0.00

1.2

1.7

2.00

1.34

ug/l

0.38

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

142

1.01

0.00

1.1

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

168

1.00

0.00

1.1

1.3

28.90

62.22

g/l

0.50

137

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

117

1.01

0.00

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.04

0.00

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.99

0.00

1.2

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

158

1.01

0.00

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

240

1.02

0.00

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

153

0.99

0.00

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

140

1.02

0.00

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

144

1215

1.00

0.00

1.4

1.5

3.15

4.30

iu/l

1.23

328

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

145

1224

1.00

0.00

2.0

2.2

36.33

29.67

mg/l

0.55

286

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

0.97

0.00

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

767

1.00

0.00

1.5

1.60

2.89

mg/l

2.33

596

(3001019) Free T4 and TSH panel - Serum or Plasma

404

1.00

0.00

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.00

0.00

1.0

1.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

191

1.01

0.00

1.2

1.3

22.06

27.98

0.45

126

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.05

0.00

1.2

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

1.25

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.2

—

11.67

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.3

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

3.44

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.98

-0.00

1.1

1.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

2.18

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.90

-0.00

1.5

1.2

—

(3016879) Cocaine [Presence] in Urine

0.95

-0.00

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.99

-0.00

1.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.88

-0.00

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.84

-0.00

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.50

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

18.20

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AD_LO – Alzheimer’s disease (Late onset)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer’s disease (Late onset)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer’s disease (Late onset) (AD_LO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints